Cimetidine is a histamine H2-receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. It is a reversible, competitive antagonist, and is used as an anti-ulcer drug.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Cimetidine is the active ingredient of these drugs:
South Africa
South Africa
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Ireland
Hong Kong
Hong Kong
Hong Kong
Ecuador
South Africa
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Japan
South Africa
Hong Kong
South Africa
South Africa
Hong Kong
Singapore
Hong Kong
Brazil
South Africa
South Africa
Hong Kong
Hong Kong
Tunisia
Turkey
South Africa
Hong Kong Singapore
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Brazil Japan Mexico South Africa United Kingdom
Hong Kong
Cyprus
Hong Kong
Hong Kong
Hong Kong
Hong Kong
South Africa
South Africa
Hong Kong
Hong Kong
Brazil
Cyprus Hong Kong
Austria
South Africa
Hong Kong
Hong Kong
Tunisia
Hong Kong Singapore